Treatment of motor fluctuations in Parkinson’s disease (PD) remains an unmet challenge. Adenosine 2A (A2A) receptors are located along the indirect pathway and represent a potential target to enhance L-3,4-dihydroxyphenylalanine (L-DOPA) antiparkinsonian action.
Articles Collection
- This article collection was made possible by Cynapsus.
Footer
Copyright © 1999-2024 John Wiley & Sons, Inc. All Rights Reserved.
